BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti–PD-1 Antibody

Title
BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti–PD-1 Antibody
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 24, Issue 14, Pages 3377-3385
Publisher
American Association for Cancer Research (AACR)
Online
2018-04-12
DOI
10.1158/1078-0432.ccr-17-1914

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now